As of April 15, 2025, Swedish Orphan Biovitrum (SOBI.ST) has a market cap of $9.28 billion USD. According to our data, Swedish Orphan Biovitrum is ranked No.1705 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $9.28 B |
-16.06%
|
Dec 30, 2024 | $11.05 B |
18.88%
|
Dec 29, 2023 | $9.30 B |
29.59%
|
Dec 30, 2022 | $7.17 B |
16.53%
|
Dec 30, 2021 | $6.16 B |
11.44%
|
Dec 30, 2020 | $5.52 B |
7.51%
|
Dec 30, 2019 | $5.14 B |
-19.95%
|
Dec 28, 2018 | $6.42 B |
71.86%
|
Dec 29, 2017 | $3.74 B |
5.25%
|
Dec 30, 2016 | $3.55 B |
-20.73%
|
Dec 30, 2015 | $4.48 B |
69.63%
|
Dec 30, 2014 | $2.64 B |
18.88%
|
Dec 30, 2013 | $2.22 B |
82.38%
|
Dec 28, 2012 | $1.22 B |
148.98%
|
Dec 30, 2011 | $0.49 B |
-59.44%
|
Dec 30, 2010 | $1.21 B |
45.68%
|
Dec 30, 2009 | $0.83 B |
27.35%
|
Dec 30, 2008 | $0.65 B |
-42.63%
|
Dec 28, 2007 | $1.13 B |
-33.33%
|
Dec 29, 2006 | $1.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
![]() Denmark
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Carlisle Companies
CSL
|
$15.55 B |
-0.000 M
|
![]() USA
|
![]() Seabridge Gold
SA
|
$1.25 B |
0.000 M
|
![]() Canada
|
![]() Jazz Pharmaceuticals
JAZZ
|
$6.25 B |
0.000 M
|
![]() Ireland
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
Market Cap | = | SOBI.ST Stock Price | * | SOBI.ST Shares Outstanding |
= | $27.01 | * | 0.34 B | |
= | $9.28 B |